default author photo

Emily Phijffer

Utrecht University - Department of Pediatrics

SCHOLARLY PAPERS

1

DOWNLOADS

108

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Cost-Effectiveness of Monoclonal Antibody and Maternal Immunization Against Respiratory Syncytial Virus (RSV) in Infants: Evaluation for Six European Countries

Number of pages: 23 Posted: 05 Oct 2022
University of Aberdeen - Health Economics Research Unit, University of Antwerp - Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), University of Antwerp - Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Statens Serums Institut - Department of Virus and Microbiological Special Diagnostics, University of Padua - Division of Paediatric Infectious Diseases, NIVEL (Netherlands Institute for Health Services Research), Nanjing Medical University - School of Public Health, Sanofi - France, University of Padua - Institute of Pediatric Research, Utrecht University - Department of Pediatrics, Università degli Studi di Pisa - Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Roskilde University - Department of Science and Environment, University of Turku - Department of Pediatrics, Utrecht University - Department of Pediatrics, University of Antwerp - Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), New York University (NYU), University of Antwerp - Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID) and University of Antwerp - Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID)
Downloads 108 (649,907)

Abstract:

Loading...

respiratory syncytial virus (RSV), disease burden, cost-effectiveness analysis, maternal immunization, monoclonal antibody, seasonal program, perspective, expected value of perfect information (EVPI), expected value of partial perfect information (EVPPI)